Cite
HARVARD Citation
Dziadziuszko, R. et al. (2021). Updated Integrated Analysis of the Efficacy and Safety of Entrectinib in Locally Advanced or Metastatic ROS1 Fusion–Positive Non–Small-Cell Lung Cancer. Journal of clinical oncology. 39 (11), pp. 1253-1263. [Online].